The store will not work correctly when cookies are disabled.
8-Cyclohexyl-6-(3-hydroxypropyl)imidazo[1,2-c]pyrimidin-5(6H)-one
ID: ALA4745418
PubChem CID: 162647956
Max Phase: Preclinical
Molecular Formula: C15H21N3O2
Molecular Weight: 275.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1n(CCCO)cc(C2CCCCC2)c2nccn12
Standard InChI: InChI=1S/C15H21N3O2/c19-10-4-8-17-11-13(12-5-2-1-3-6-12)14-16-7-9-18(14)15(17)20/h7,9,11-12,19H,1-6,8,10H2
Standard InChI Key: QEIMEFKQKMFRHD-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
8.7869 -22.8318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7869 -23.6490 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4921 -24.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1974 -23.6490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4921 -22.4191 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1983 -22.8324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8096 -22.2885 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4812 -21.5390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6670 -21.6199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0778 -22.4291 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9043 -24.0590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8998 -24.8759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6058 -25.2858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3153 -24.8785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3143 -24.0571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6077 -23.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0798 -24.0586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0809 -24.8758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3738 -25.2855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3750 -26.1026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 5 1 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 2 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 11 1 0
2 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 275.35 | Molecular Weight (Monoisotopic): 275.1634 | AlogP: 1.93 | #Rotatable Bonds: 4 |
Polar Surface Area: 59.53 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.58 | CX LogD: 1.58 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.93 | Np Likeness Score: -0.82 |
References
1. Jansa J,Jorda R,Škerlová J,Pachl P,Peřina M,Řezníčková E,Heger T,Gucký T,Řezáčová P,Lyčka A,Kryštof V. (2021) Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure., 216 [PMID:33711765] [10.1016/j.ejmech.2021.113309] |